Category Archives: Healthcare

Amgen Inc Gets a Buy Rating from Cowen & Co.

Cowen & Co. analyst Eric Schmidt maintained a Buy rating on Amgen Inc (NASDAQ: AMGN) today and set a price target of $204. The company’s shares opened today at $171.94. According to TipRanks.com, Schmidt is a top 25 analyst with

Analysts’ Top Healthcare Picks: DRNA, EPZM

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dicerna Pharma (NASDAQ: DRNA) and Epizyme (NASDAQ: EPZM) with bullish sentiments. Dicerna Pharma (NASDAQ: DRNA) In a report released yesterday, Ritu Baral

Staar Surgical Company Receives a Buy from Canaccord Genuity

In a report released today, Jason Mills from Canaccord Genuity reiterated a Buy rating on Staar Surgical Company (NASDAQ: STAA), with a price target of $21. The company’s shares opened today at $16.15. Mills observed: “We hosted CEO Caren Mason

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen Inc (NASDAQ: AMGN), Tesaro (NASDAQ: TSRO) and Spero Therapeutics Inc (NASDAQ: SPRO)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen Inc (NASDAQ: AMGN), Tesaro (NASDAQ: TSRO) and Spero Therapeutics Inc (NASDAQ: SPRO). TipRanks has tracked 36,000 company insiders and found that a few of

Analysts Offer Insights on Healthcare Companies: Amgen Inc (NASDAQ: AMGN), Tesaro (NASDAQ: TSRO) and Spero Therapeutics Inc (NASDAQ: SPRO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen Inc (NASDAQ: AMGN), Tesaro (NASDAQ: TSRO) and Spero Therapeutics Inc (NASDAQ: SPRO). TipRanks has tracked 36,000 company insiders and found that a

Canaccord Genuity Thinks Golden Leaf Holdings’ Stock is Going to Recover

Wall Street analyst has provided a review for the Healthcare company today, but retained the same rating on the stock. Golden Leaf Holdings (CNQX: GLH) received a Buy rating from Canaccord Genuity’s analyst Matt Bottomley, with a C$0.60 price target.